March 14th, 2013
CardioExchange’s Rick Lange and David Hillis ask Frans Van de Werf, principal investigator for the STREAM study, about his study group’s findings and their implications for clinical practice. THE STUDY In the STREAM trial, investigators compared two treatment strategies in STEMI patients presenting early after symptom onset who were unable to undergo primary PCI within 1 hour: […]
March 10th, 2013
Deepak Bhatt sheds light on findings from the CHAMPION PHOENIX trial and their implications for clinical practice.
February 22nd, 2013
The 5 year results of the SYNTAX (SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery) trial are now published. SYNTAX assessed the optimal revascularization strategy for patients with left main and/or 3-vessel disease by randomly assigning such patients to CABG or PCI (with a first-generation paclitaxel-eluting stent) and then determining the rate of […]
February 14th, 2013
According to the recently published results of the WOEST trial, patients receiving anticoagulation thereapy who undergo stenting have better outcomes with clopidogrel only than with clopidogrel plus aspirin. Rick Lange and David Hillis ask: Are you ready to stop prescribing aspirin to these patients?
February 7th, 2013
Megan Coylewright, MD MPH, Michael Tempelhof, MD MSc, Micah Eimer, MD, L. David Hillis, MD, Richard A. Lange, MD, MBA and John Ryan, MD
According to an ESC consensus document published last week, radial artery access should be the “default” choice for PCI. CardioExchange’s John Ryan interviewed cardiologists and interventional cardiologists at different stages of their careers to find out how they view radial artery catheterization, and if the views differ among interventional fellows, faculty, and those in leadership roles. Dr. […]
February 6th, 2013
David Hillis and Rick Lange consider new evidence that iFR is not an acceptable substitute for FFR. Does the need for adenosine administration hinder the use of FFR to guide management decisions?
January 8th, 2013
A recent rash of lawsuits and physician suspensions for “unnecessary PCI” have given many interventionalists pause. Rick Lange and David Hillis ponder the implications of these incidents on clinical practice.
December 20th, 2012
Renal denervation for resistant hypertension is generating a lot of excitement. In this blog, Rick Lange and David Hillis take stock of the evidence and the efforts underway to explore the potential scope of indications for the procedure.
September 19th, 2012
Dr. Deepak Bhatt ponders the clinical implications of two studies suggesting that early discontinuation of dual antiplatelet therapy is safe — and concludes that the findings will probably not change his practice.
August 28th, 2012
The FAME 2 trial adds fuel to the debate regarding what measurements should guide decisions about revascularization.